- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Bayer's Eylea declines by 24%, bearing the brunt of biosmilar competition | ||
| Di | EU advances scheme to bolster manufacturing autonomy, avert drug shortages | ||
| Di | Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer | ||
| Mo | CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion | ||
| Mo | Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer | ||
| Mo | Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan | ||
| Mo | OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint | ||
| Mo | Eli Lilly shoots for health in new Caitlin Clark ad campaign | ||
| 08.05. | Targeted Protein Degradation and Novel Modalities: Getting on the Frontline | ||
| 08.05. | Trump plans to fire FDA chief Marty Makary: report | ||
| 08.05. | Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill | ||
| 08.05. | Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma | ||
| 08.05. | Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory' | ||
| 08.05. | Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild | ||
| 08.05. | AbbVie's Skyrizi beats out J&J's Tremfya in in April drug ad spending leaderboard | ||
| 08.05. | Johnson & Johnson launches 'Generation Fine' depression project | ||
| 08.05. | Revisiting Pharma's tariff reality | ||
| 08.05. | GSK tees up a Modern Family for meningitis messaging | ||
| 08.05. | Pre-launch efforts linked to lasting drug awareness edge: report | ||
| 07.05. | Angelini finds Catalyst for its US growth ambitions with $4.1B buyout | ||
| 07.05. | FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next? | ||
| 07.05. | Insulet CEO details 'Scrubs' device promotion win as it boosts awareness, education drive | ||
| 07.05. | Alnylam rebuked by FDA over efficacy claims on Amvuttra website | ||
| 06.05. | Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report | ||
| 06.05. | FDA rolls out 1-day assessment pilot in bid to refocus inspection resources |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.